pentobarbital has been researched along with Liver Steatosis in 3 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kolata, GB | 1 |
| Rubin, E | 1 |
| Bacchin, P | 1 |
| Gang, H | 1 |
| Lieber, CS | 1 |
| Weisburger, JH | 1 |
| Schmehl, EA | 1 |
| Pai, SR | 1 |
3 other studies available for pentobarbital and Liver Steatosis
| Article | Year |
|---|---|
Reye's syndrome: a medical mystery.
Topics: Brain Edema; Fatty Liver; Humans; Intracranial Pressure; Mannitol; Mitochondria, Liver; Pentobarbita | 1980 |
Induction and inhibition of hepatic microsomal and mitochondrial enzymes by ethanol.
Topics: Acyltransferases; Alcoholism; Aniline Compounds; Animals; Benzopyrenes; Centrifugation; Chemical and | 1970 |
Liver damage by the carcinogen N-hydroxy-N-2-fluorenylacetamide. Pentobarbital sleeping time and liver morphology.
Topics: Anesthesia; Animals; Biotransformation; Carcinogens; Fatty Liver; Fluorenes; Liver; Liver Cirrhosis; | 1965 |